ArticleRSC advances2024
Hydrophilicity and surface charge modulation of Ti
Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Structure-transport relationships in MXene-based membranes: from synthesis to selective water treatment.Nanoscale advances · 2026Review
- Large-Scale MXene Membrane Fabrication via Nonsolvent Phase Separation.Small methods · 2026Article
- Au anchoring on 3D hierarchically porous TiRSC advances · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Lamellar membranes obtained by stacking 2D layers possess ample transport pathways due to their intricate network of interlayer gaps. This makes them suitable for molecular separation applications. However, controlling the surface chemistry of the nanochannels within the membrane to tune the desired transport properties of water and ions is challenging. Ti
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.